1996
DOI: 10.1016/s0005-2760(96)00126-9
|View full text |Cite
|
Sign up to set email alerts
|

Interaction of liposomes with human skin in vitro — The influence of lipid composition and structure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
84
1
1

Year Published

2002
2002
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 232 publications
(88 citation statements)
references
References 19 publications
2
84
1
1
Order By: Relevance
“…Kirjavainen et al reported in 1996 that the fluorescence from liposomal compositions con- taining DOPE (dioleylphosphatidyl ethanolamine) were able to penetrate deeper into the SC than that from liposomes without DOPE. A pretreatment of skin with unlabeled liposomes containing DOPE or lyso-phosphatidylcholine (lyso-PC) enhanced the subsequent penetration of the fluorescent markers, N-Rh-PE and sulforhodamine B into the skin, suggesting possible enhancer activity (Kirjavainen et al, 1996). In 1997, Boderke et al used CLSM to show that the amino peptidase activity was evenly distributed throughout the viable part of the epidermis, with enhanced fluorescence in the upper layers of the stratum granulosum, while dermis and SC showed considerably less amino peptidase activity (Boderke et al, 1997 demonstrate that vesicles made of native human SC lipids rapidly interact with phosphatidylserine liposomes, weakly with human stratum corneum lipid liposomes and have no effect on PC liposomes (Zellmer et al, 1998).…”
Section: Resultsmentioning
confidence: 99%
“…Kirjavainen et al reported in 1996 that the fluorescence from liposomal compositions con- taining DOPE (dioleylphosphatidyl ethanolamine) were able to penetrate deeper into the SC than that from liposomes without DOPE. A pretreatment of skin with unlabeled liposomes containing DOPE or lyso-phosphatidylcholine (lyso-PC) enhanced the subsequent penetration of the fluorescent markers, N-Rh-PE and sulforhodamine B into the skin, suggesting possible enhancer activity (Kirjavainen et al, 1996). In 1997, Boderke et al used CLSM to show that the amino peptidase activity was evenly distributed throughout the viable part of the epidermis, with enhanced fluorescence in the upper layers of the stratum granulosum, while dermis and SC showed considerably less amino peptidase activity (Boderke et al, 1997 demonstrate that vesicles made of native human SC lipids rapidly interact with phosphatidylserine liposomes, weakly with human stratum corneum lipid liposomes and have no effect on PC liposomes (Zellmer et al, 1998).…”
Section: Resultsmentioning
confidence: 99%
“…Confocal microscopic studies showed that intact fluorescent labeled liposomes were not able to penetrate into the granular layers of the epidermis. 1) Since the first paper to report the effectiveness of deformable liposomes which can be used for skin delivery of drug into deep skin region was published by Cevc and Blume, 2) new categories of vesicles with high elasticity or flexibility, such as transfersomes, 3) ethosomes, 4) flexosomes 5) and invasomes 6) have been introduced and developed. These vesicles mainly consist of phospholipids and an edge activator or penetration enhancer in which only a specially designed vesicle was shown to be able to allow transdermal drug delivery.…”
mentioning
confidence: 99%
“…It is not clear why the drug loaded into cationic liposomes resulted in greater penetration over anionic liposomes. But it appears that cationic charge on the surface of liposome played a role because epidermis layer contains negatively charged lipids (Burnette and Ongpipattanakul, 1987;Kirjavainen et al, 1996). This speculation is further supported by the fact that the higher percentage of DOTAP shows the greater penetration.…”
Section: Resultsmentioning
confidence: 94%